Metabolomics Workbench : NIH Data Repository

Clustering data with hclust algorithm for (Study ST002686)

(Analysis AN004359)

Metabolite	Structure	F1	F2	F3	F4	F5	F6	F7	F8	F9	F10	F11	F12	F13	F14
FA(18:4)	ME635266	1.43	0.20	0.92	0.60	7.11	0.89	0.69	0.27	0.58	0.31	0.95	0.45	0.79	0.52
beta-muricholate	ME635295	0.81	0.41	0.90	0.96	5.44	1.06	0.84	0.30	0.53	0.90	1.05	0.26	0.41	0.94
cholate	ME635294	0.57	0.05	0.89	0.68	6.33	1.12	1.76	0.06	1.33	0.56	1.15	0.01	0.18	0.20
glycohyodeoxycholate	ME635300	0.81	0.20	0.75	0.41	7.55	0.17	1.74	1.51	1.32	0.27	0.43	0.28	0.32	0.60
glycoursodeoxycholate	ME635299	0.82	0.21	0.74	0.41	7.58	0.15	1.74	1.51	1.30	0.28	0.43	0.28	0.32	0.62
chenodeoxycholate	ME635292	0.65	0.11	0.76	0.78	8.72	0.58	0.92	0.14	1.45	0.28	0.74	0.12	0.22	0.29
ursodeoxycholate	ME635291	0.34	0.13	1.04	0.68	9.08	0.26	1.67	0.47	1.90	0.54	0.39	0.37	0.30	0.23
glycocholate	ME635301	0.92	0.31	0.91	0.70	0.52	0.23	0.99	6.98	0.57	0.24	0.86	0.04	0.58	0.76
glycohyocholate	ME635302	0.91	0.31	0.90	0.70	0.52	0.23	0.99	6.98	0.57	0.24	0.86	0.04	0.58	0.75
glycodeoxycholate	ME635298	0.84	0.48	0.99	0.60	0.91	0.35	1.03	6.08	0.60	0.65	0.61	0.36	0.51	1.74
taurocholate	ME635309	1.06	0.36	1.22	1.00	0.03	0.25	0.77	5.71	0.57	0.30	0.86	0.22	0.23	1.59
tauro-alpha-muricholate	ME635308	1.58	0.25	0.44	0.27	0.17	0.18	0.59	8.59	0.54	0.24	0.88	0.28	0.30	1.53
taurohyodeoxycholate	ME635303	0.45	0.24	0.75	0.65	NA	0.34	0.35	8.51	0.22	0.21	0.36	0.23	0.20	1.38
tauro-alpha-muricholate + tauro-beta-muricholiate	ME635307	0.63	0.30	0.89	0.82	0.07	0.26	0.40	7.69	0.28	0.31	0.49	0.26	0.16	2.31
tauro-beta-muricholate	ME635305	0.52	0.30	0.90	0.82	0.03	0.24	0.27	8.01	0.16	0.31	0.36	0.27	0.10	2.64
taurohyocoholate	ME635306	0.52	0.30	0.92	0.82	0.03	0.24	0.28	7.92	0.18	0.31	0.38	0.27	0.11	2.67
phenyllactate	ME635233	0.53	1.20	0.90	0.50	0.93	0.85	0.41	4.21	0.54	1.46	0.33	0.58	0.50	2.05
glycochenodeoxycholate	ME635297	1.91	0.30	1.21	0.76	1.09	0.43	1.73	3.24	1.27	0.48	1.42	0.35	0.76	0.85
tauroursodeoxycholate	ME635304	1.07	0.33	0.93	0.68	0.61	0.33	1.77	4.63	1.02	0.60	0.87	0.54	0.45	0.71
uridine	ME635258	0.53	0.82	0.41	0.27	2.70	4.24	0.36	0.66	0.33	0.36	0.73	0.53	0.72	0.89
threonine	ME635220	0.45	0.50	0.60	3.33	0.63	0.91	0.69	0.71	0.59	0.57	0.54	0.63	0.51	0.60
3-methyl-2-oxovalerate	ME635222	0.52	0.40	1.16	0.46	0.44	3.28	1.22	0.93	1.31	0.78	0.68	0.57	0.44	0.41
ketoleucine	ME635223	0.70	0.33	1.25	0.51	0.35	3.23	1.44	0.85	1.35	0.67	0.58	0.44	0.46	0.32
FA(22:0)	ME635285	1.91	0.27	0.84	0.59	1.52	2.23	1.50	0.68	1.38	0.72	1.14	0.75	0.89	1.10
N-acetylleucine	ME635235	1.44	0.71	0.65	0.46	1.19	2.92	0.98	0.63	0.99	0.54	0.93	0.49	1.16	0.75
alpha-muricholate	ME635296	1.46	0.49	1.01	0.72	3.34	0.87	1.30	0.36	0.57	0.68	1.78	0.50	0.85	0.99
FA(20:5(5Z,8Z,11Z,14Z,17Z)))	ME635275	1.54	0.52	0.93	0.88	3.16	1.33	0.76	0.40	0.78	0.44	1.32	0.64	0.94	0.81
deoxycholate	ME635293	0.86	0.45	1.07	1.06	1.96	0.84	1.74	0.53	1.51	0.76	1.09	0.66	0.64	0.81
FA(10:0-OH)	ME635243	1.66	0.59	1.90	1.07	2.11	0.53	0.79	0.56	0.68	0.53	0.87	0.79	0.71	1.00
FA(14:1)	ME635255	4.11	0.42	1.15	0.81	1.58	0.38	1.34	0.41	1.30	0.54	1.96	0.49	1.53	0.76
FA(14:0-OH)	ME635259	2.89	0.67	1.17	1.31	0.09	0.27	1.11	0.41	1.15	0.50	1.99	0.85	1.83	1.36
FA(16:0-OH)	ME635265	2.21	0.68	1.21	1.21	0.08	0.11	1.45	0.62	1.40	0.74	1.97	0.93	1.94	1.61
kynurenate	ME635244	2.97	0.63	0.91	0.60	0.53	0.93	1.00	0.40	1.33	0.27	1.91	0.72	2.40	0.30
FA(12:0-OH)	ME635253	3.37	0.56	1.14	0.66	0.13	0.50	1.27	0.42	1.30	0.47	2.24	0.54	1.59	0.69
FA(14:2)	ME635254	3.32	0.40	1.13	0.68	0.32	0.26	1.47	0.52	1.26	0.72	2.18	0.61	1.41	0.72
3-hydroxybutyrate	ME635216	2.16	0.33	1.17	0.87	0.40	0.41	1.92	0.49	2.35	0.55	1.35	0.58	1.34	0.39
hydroxyindole acetate	ME635245	4.02	0.57	1.09	0.64	0.44	0.34	1.74	0.79	1.60	0.79	1.18	0.61	0.71	0.44
indole lactate	ME635250	3.15	0.49	1.04	0.68	0.32	0.25	1.65	0.77	1.71	0.99	1.39	0.82	0.99	0.75
glutarate	ME635224	1.56	0.55	0.84	1.87	1.57	0.70	0.72	0.38	0.79	0.15	1.15	0.95	1.67	0.24
FA(8:0-COOH)	ME635237	1.03	0.76	1.65	0.90	1.30	1.71	0.63	0.81	0.66	0.60	0.82	0.66	0.94	0.63
FA(8:0-OH)	ME635230	1.07	0.58	1.38	1.35	0.67	1.77	0.72	0.62	0.79	0.62	0.82	0.63	0.92	0.65
FA(10:0-COOH)	ME635248	2.19	0.69	1.57	1.89	0.69	0.76	0.75	0.73	0.68	0.59	0.82	0.55	0.70	1.24
FA(16:0-COOH)	ME635272	1.48	0.63	1.29	1.86	1.10	1.24	1.01	0.59	1.00	0.54	0.88	0.55	0.84	0.93
FA(11:0-COOH)	ME635252	2.85	0.70	1.97	1.20	0.80	0.65	1.15	0.56	0.64	0.43	0.89	0.68	0.68	1.58
FA(9:0-COOH)	ME635242	2.66	0.65	2.11	1.12	0.60	0.70	1.18	0.81	0.82	0.53	1.00	0.57	0.74	0.79
FA(22:6(4Z,7Z,10Z,16Z,19Z))	ME635281	1.20	0.90	1.05	1.12	1.61	1.21	1.06	0.94	1.02	0.95	1.24	1.04	1.05	1.12
serine	ME635217	1.27	1.24	0.88	0.71	1.66	1.22	1.17	1.02	1.02	1.11	1.10	1.20	1.27	1.21
FA(15:0)	ME635257	1.31	0.61	1.44	0.91	1.54	1.49	1.07	0.78	0.98	1.13	1.10	0.71	1.01	1.06
FA(17:0)	ME635264	1.48	0.51	1.38	0.84	1.56	1.05	1.43	0.71	1.18	1.05	1.39	0.79	1.10	1.32
2-hydroxybutyrate	ME635215	1.32	0.84	1.03	0.72	0.69	1.86	1.07	0.82	1.14	0.79	0.90	0.83	0.96	0.68
N-acetylphenylalanine	ME635251	1.05	0.71	0.95	1.24	0.91	1.44	1.02	0.85	0.99	0.81	0.87	0.91	0.64	1.02
retinoate	ME635274	0.99	0.97	1.19	1.17	0.86	0.97	1.02	0.98	1.00	1.06	1.00	1.00	1.03	0.96
urate	ME635234	1.58	1.01	1.00	0.73	0.85	1.26	1.01	0.88	1.01	0.89	1.09	0.82	1.00	1.22
FA(22:4)	ME635283	1.37	0.97	1.10	1.13	0.83	1.09	1.22	0.92	1.25	1.03	1.32	0.87	1.04	1.37
indoleacrylate	ME635241	1.36	0.85	0.98	0.92	0.86	1.03	1.15	0.90	1.15	0.89	1.19	0.90	0.91	1.03
sphingosine-1P (C18)	ME635289	1.44	1.11	0.75	0.45	1.55	1.28	1.66	1.20	1.61	0.94	1.43	0.93	1.10	0.85
hyodeoxycholate	ME635290	1.03	0.56	1.17	0.77	0.59	0.81	1.75	0.82	1.59	0.99	1.23	1.05	0.86	0.88
FA(18:2)	ME635268	1.86	0.70	1.08	0.54	1.20	1.21	1.21	0.81	1.53	1.16	1.54	0.97	1.17	1.15
FA(18:1)	ME635269	1.88	0.60	1.27	0.85	1.16	1.02	1.52	0.76	1.43	1.00	1.39	0.80	1.08	1.00
FA(22:5)	ME635282	1.89	0.63	1.06	1.03	1.34	0.94	1.49	0.60	1.66	0.78	1.63	0.57	1.23	1.05
lactate	ME635214	1.71	1.18	1.19	0.60	0.93	1.03	1.29	1.12	1.16	1.00	1.39	1.12	1.39	0.95
phenylalanine	ME635232	1.62	0.91	1.16	0.55	0.63	0.71	1.33	1.00	1.37	1.04	1.36	0.89	1.08	1.01
tyrosine	ME635239	1.47	0.84	1.07	0.58	0.98	0.93	1.38	0.95	1.45	1.01	1.14	0.77	1.02	1.02
gamma-glutamylisoleucine	ME635262	1.48	0.71	1.18	0.58	0.84	0.87	1.32	0.80	1.66	0.91	1.48	0.72	1.09	0.81
gamma-glutamylleucine	ME635263	1.48	0.70	1.18	0.58	0.84	0.87	1.32	0.79	1.66	0.91	1.49	0.72	1.09	0.81
hydroxyphenyllactic acid	ME635240	1.47	0.64	1.14	0.65	0.88	0.84	1.40	0.87	1.42	0.90	1.29	0.90	1.17	0.89
tryptophan	ME635249	1.72	0.79	1.10	0.55	0.76	0.93	1.33	0.87	1.44	0.91	1.33	0.81	1.11	0.93
histidine	ME635229	0.83	0.84	1.22	0.93	0.27	0.52	1.46	1.43	1.22	1.37	1.15	0.97	1.14	0.50
S-allylcysteine	ME635231	1.55	0.89	1.19	1.20	0.10	0.22	1.14	0.79	1.22	0.68	1.78	0.85	1.29	1.74
citrate	ME635246	1.43	0.66	1.08	1.56	0.29	0.22	1.36	0.82	1.34	0.81	1.31	0.84	1.12	0.78
glutamine	ME635227	1.59	1.13	1.29	0.76	0.52	0.62	1.40	1.25	1.56	1.21	1.54	1.04	1.06	0.88
cis-aconitate	ME635236	1.71	0.88	1.11	0.67	0.42	0.33	1.53	0.92	1.55	0.98	1.56	0.96	1.31	0.85
AMP	ME635286	1.59	0.93	1.08	1.02	0.25	0.13	1.46	0.86	1.47	0.96	1.53	0.95	1.17	1.04
malate	ME635226	1.67	0.99	1.09	0.86	0.23	0.13	1.42	1.06	1.34	1.03	1.42	1.18	1.20	1.03
succinate	ME635219	2.13	1.43	0.85	0.51	0.28	0.38	1.24	0.87	1.16	0.75	1.63	1.17	1.72	1.11
xanthosine	ME635270	2.40	1.37	1.08	0.83	0.33	0.37	1.17	0.68	1.22	0.76	1.69	0.63	1.17	0.98
FA(20:4)	ME635276	2.55	1.18	0.55	0.58	1.21	0.99	1.17	0.97	1.32	0.93	1.57	1.28	1.13	1.71
maleate	ME635218	2.39	0.98	1.01	0.48	0.28	0.47	1.41	0.95	1.31	1.06	1.40	1.15	1.04	1.25
glutamate	ME635228	2.72	1.10	1.04	0.71	0.75	0.65	1.34	0.76	1.15	0.80	1.50	1.21	1.31	1.68
taurine	ME635221	2.21	1.12	1.02	0.69	0.81	0.50	1.20	1.10	1.19	1.06	1.67	1.23	1.42	1.50
FA(24:1)	ME635287	2.77	0.26	0.87	0.56	0.49	1.55	1.51	0.54	1.10	0.75	1.10	0.83	1.10	1.24
hippurate	ME635238	2.86	0.65	1.07	0.54	0.81	1.25	0.94	0.31	1.07	0.72	1.58	0.77	1.36	0.71
FA(16:1)	ME635260	2.50	0.48	1.35	0.94	2.01	0.86	1.39	0.52	1.35	0.70	1.40	0.49	1.18	0.75
FA(18:3)	ME635267	2.20	0.44	1.26	0.83	1.88	1.56	1.25	0.53	1.11	0.67	1.28	0.64	1.07	0.95
FA(19:1)	ME635273	2.45	0.38	1.07	0.71	1.65	1.16	1.13	0.46	0.97	0.70	1.22	0.53	1.13	1.14
FA(12:0)	ME635247	3.00	0.50	1.55	0.98	1.14	0.55	1.19	0.47	1.16	0.62	1.81	0.42	1.25	1.24
FA(20:0)	ME635280	1.72	0.37	1.39	0.80	0.60	0.66	1.79	0.59	1.42	0.88	1.75	0.86	1.75	1.58
FA(20:1)	ME635279	1.99	0.50	1.31	0.84	0.76	0.96	1.58	0.73	1.29	0.96	1.46	0.87	1.36	1.31
FA(24:0)	ME635288	2.38	0.35	1.16	0.73	0.55	0.95	1.83	0.68	1.54	0.87	1.49	1.08	1.11	1.27
FA(18:0)	ME635271	1.78	0.53	1.35	0.78	0.58	0.60	1.85	0.76	1.70	1.04	1.87	0.77	1.24	1.05
FA(22:3)	ME635284	2.26	0.47	1.05	0.67	0.63	0.54	1.74	0.56	1.50	0.84	1.80	0.50	1.16	1.21
FA(14:0)	ME635256	2.31	0.47	1.34	0.86	1.30	0.56	1.70	0.56	1.71	0.66	1.85	0.54	1.30	0.88
FA(16:0)	ME635261	1.99	0.57	1.37	0.86	1.17	0.41	1.65	0.78	1.51	0.99	1.66	0.77	1.24	1.08
aspartate	ME635225	2.59	0.78	1.13	0.71	1.01	0.58	1.25	0.71	1.17	0.79	1.21	0.82	1.02	1.09
FA(20:2)	ME635278	2.39	0.53	1.22	0.80	1.32	1.14	1.41	0.62	1.12	0.84	1.48	0.67	1.22	1.33
FA(20:3)	ME635277	2.36	0.48	1.03	0.67	1.17	0.87	1.46	0.52	1.31	0.68	1.62	0.50	1.19	0.90

Factors:

F1	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Female
F2	Group:Control \| Timepoint:8 weeks of training or control time \| Sex:Male
F3	Group:QC-DriftCorrection \| Timepoint:0 hour \| Sex:-
F4	Group:QC-Pooled \| Timepoint:0 hour \| Sex:-
F5	Group:QC-ReCAS \| Timepoint:0 hour \| Sex:-
F6	Group:QC-Reference \| Timepoint:0 hour \| Sex:-
F7	Group:Training \| Timepoint:1 week of training or control time \| Sex:Female
F8	Group:Training \| Timepoint:1 week of training or control time \| Sex:Male
F9	Group:Training \| Timepoint:2 weeks of training \| Sex:Female
F10	Group:Training \| Timepoint:2 weeks of training \| Sex:Male
F11	Group:Training \| Timepoint:4 weeks of training \| Sex:Female
F12	Group:Training \| Timepoint:4 weeks of training \| Sex:Male
F13	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Female
F14	Group:Training \| Timepoint:8 weeks of training or control time \| Sex:Male

Data matrix